KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Thermo Fisher Scientific (TMO) Receivables - Other (2018 - 2025)

Thermo Fisher Scientific's Receivables - Other history spans 8 years, with the latest figure at $1.7 billion for Q4 2025.

  • For the quarter ending Q4 2025, Receivables - Other rose 16.1% year-over-year to $1.7 billion, compared with a TTM value of $1.7 billion through Dec 2025, up 16.1%, and an annual FY2025 reading of $1.7 billion, up 16.1% over the prior year.
  • Receivables - Other for Q4 2025 was $1.7 billion at Thermo Fisher Scientific, up from $1.6 billion in the prior quarter.
  • The five-year high for Receivables - Other was $1.7 billion in Q4 2025, with the low at $783.0 million in Q2 2021.
  • Average Receivables - Other over 5 years is $1.3 billion, with a median of $1.4 billion recorded in 2023.
  • Year-over-year, Receivables - Other surged 54.46% in 2022 and then dropped 3.94% in 2025.
  • Tracing TMO's Receivables - Other over 5 years: stood at $968.0 million in 2021, then surged by 35.54% to $1.3 billion in 2022, then grew by 9.98% to $1.4 billion in 2023, then decreased by 0.55% to $1.4 billion in 2024, then rose by 16.1% to $1.7 billion in 2025.
  • Per Business Quant, the three most recent readings for TMO's Receivables - Other are $1.7 billion (Q4 2025), $1.6 billion (Q3 2025), and $1.4 billion (Q2 2025).